The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Zoledronic acid Actavis

Actavis Group hfEU/1/12/759/001-003

Main Information

Trade NameZoledronic acid Actavis
Active SubstancesZoledronic acid monohydrate
Dosage FormConcentrate for solution for infusion
Licence HolderActavis Group hf
Licence NumberEU/1/12/759/001-003

Group Information

ATC CodeM05BA Bisphosphonates
M05BA08 zoledronic acid


License statusAuthorised
Licence Issued
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website

Educational Materials - Patient

« Back